Glimepiride Strandhaven (Glimepiride)

Glimepiride Strandhaven is prescribed to improve glycemic control in adults diagnosed with type 2 diabetes mellitus, often as part of a comprehensive diabetes management plan that includes diet and exercise.

• Used as monotherapy when metformin alone does not achieve target glucose levels.
• Added to metformin therapy for synergistic glucose‑lowering effect.
• May be combined with other oral antidiabetic agents under physician guidance.
• Helps reduce fasting and post‑prandial blood glucose concentrations.
• Utilized in patients who can tolerate sulfonylureas without severe hypoglycemia.

Glimepiride Strandhaven may cause a range of side effects, most of which are mild and transient, while some require immediate medical attention.

Common

• Mild hypoglycemia, especially if meals are missed.
• Headache or dizziness.
• Nausea or abdominal discomfort.
• Weight gain due to increased insulin activity.

Serious

• Severe hypoglycemia leading to confusion or loss of consciousness.
• Allergic reactions such as rash, itching, or swelling.
• Hematologic abnormalities like leukopenia or thrombocytopenia.

Before starting Glimepiride Strandhaven, certain precautions should be considered to ensure safe and effective use.

• Assess renal and hepatic function, as impairment may increase drug exposure.
• Monitor blood glucose regularly to avoid hypoglycemia.
• Use cautiously in elderly patients who may be more sensitive to glucose‑lowering effects.
• Discontinue or adjust dose before surgical procedures or during acute illness.
• Avoid use during pregnancy and lactation unless clearly indicated by a healthcare professional.
• Review any history of cardiovascular disease, as sulfonylureas may affect cardiac outcomes.

Glimepiride Strandhaven can interact with several medications, altering its efficacy or safety profile.

Avoid

• Concurrent use with other sulfonylureas or insulin, which may cause severe hypoglycemia.
• Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that increase glimepiride plasma levels.
• Certain non‑steroidal anti‑inflammatory drugs (NSAIDs) that may potentiate hypoglycemic effects.

Use with caution

• Beta‑blockers, which can mask hypoglycemia symptoms.
• Thiazide diuretics, which may raise blood glucose.
• Oral contraceptives, as they may slightly reduce glimepiride effectiveness.
• Antifungal agents like ketoconazole, requiring possible dose adjustment.